
Oncology Today with Dr Neil Love
Prostate Cancer — An Interview with Prof Karim Fizazi
1 tim 2 min•23 oktober 2026
Om avsnittet
Featuring an interview with Prof Karim Fizazi, including the following topics:
- Perspectives on the PROTEUS Phase III trial evaluating the addition of apalutamide to standard therapy for high-risk localized prostate cancer (0:00)
- Mechanism of action of opevesostat and potential role in castration-resistant prostate cancer with androgen receptor mutations (15:37)
- Perspectives on alpha- and beta-emitting radiopharmaceuticals in the treatment of prostate cancer (22:47)
- Novel antibody-drug conjugates and proteolysis-targeting chimeras (30:43)
- Treatment approaches for metastatic hormone-sensitive prostate cancer — de novo symptomatic presentation versus PSMA-only metastatic recurrence after local therapy (34:51)
- Role of intermittent therapy in the treatment of prostate cancer (38:48)
- Treatment intensification approaches in prostate cancer (41:38)
- Case: A man in his late 60s with de novo PSMA PET-positive metastatic castration-sensitive prostate cancer (45:25)
Oncology Today with Dr Neil Love med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.